Skip to main
CERE
CERE logo

Cerevel Therapeutics Holdings Inc (CERE)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy CERE Stock

About Cerevel Therapeutics Holdings Inc (CERE)

Cerevel Therapeutics Holdings, Inc. engages in the discovery and development of new therapies for neuroscience diseases. The firm's portfolio focuses on diseases such as schizophrenia, epilepsy, and Parkinson's disease. Its product candidates include CVL-231, Darigabat, Tavapadon, CVL-871, and CVL-936. The company was founded in 2018 and is headquartered in Cambridge, MA.
Market cap$8.19B
Today's volume
Revenue (TTM)
Avg. daily volume1.93M
EBITDA (TTM)
Open
Price / earnings ratio-16.46x
Today's range
Debt / equity
52 week range$19.59 - $44.99
5 year debt / equity42.99x
Beta (LTM)0.39x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMay 8, 2024
Dividend payable date

CERE Stock Rating

What analysts recommend for CERE stock, on a scale from 1(buy) to 5(sell).
Hold
Strong Buy 13%
Buy 20%
Hold 67%
Sell 0%
Strong Sell 0%

Frequently Asked Questions (FAQ)

As of Jul 26, 2025, the market cap for CERE stock is $8.2B

The current P/E ratio for CERE stock is -16.46

The 52-week high for CERE stock is $44.99. The current CERE stock price $undefined is 100.00% below its 52-week high

The 52-week low for CERE stock is $19.59. The current CERE stock price $undefined has increased 100.00% from its 52-week low

No, the CERE stock does not pay dividends to its shareholders

The target price for CERE stock is $38.20 based on the average of what a group of analyst think CERE stock could be worth at a future date. This is not a prediction by Public.com

How to buy CERE stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CERE stock

    Navigate to the Explore page. Then, type CERE into the search bar. When you see CERE stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CERE stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Cerevel Therapeutics Holdings Inc Stock Earnings

The value each CERE share was expected to gain vs. the value that each CERE share actually gained.

CERE (CERE) reported Q2 2024 earnings per share (EPS) of -$0.73, missing estimates of -$0.61 by 19.67%. In the same quarter last year, CERE's earnings per share (EPS) was -$0.63. CERE is expected to release next earnings on 05/08/2024, with an earnings per share (EPS) estimate of $0.

Buy CERE Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.